🔄 From Injection to Ingestion: SOUL Sparks a CKM Revolution
May 31, 2025•2 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
📢 New from the SOUL trial!
💊 Oral semaglutide cuts heart attack risk in T2DM 🫀 but shows no benefit for stroke 🧠 or kidney disease 🧫.
A win for adherence, a push for CKM integration! 🔄💡 #Diabetes #Cardiology #NEJM #CKM #GLP1RA @doximity
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast